[Preprint] Randomized trial: Convalescent plasma not associated with improved outcomes in Covid-19

Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial) – medRxiv

Commentary on Twitter

Convalescent Plasma Randomized Controlled Trial (PLACID Trial) in the Management of Moderate #COVID19 (pre-print)

? “not associated with reduction in mortality or progression to severe COVID-19”

Link: https://t.co/2ZXnfemsas@GermHunterMD @MackayIM @CT_Bergstrom #IDTwitter pic.twitter.com/yZuOxVhbjL

— Alvin (@alvie_barr) September 8, 2020